Mutant IDH1-IN-6

Mutant IDH1-IN-6
Item number Size Datasheet Manual SDS Delivery time Quantity Price
TGM-T39716-5mg 5 mg

7 - 10 business days*

951.00€
 
Description: Mutant IDH1-IN-6 is an orally active compound that effectively inhibits mutant... more
Product information "Mutant IDH1-IN-6"
Description: Mutant IDH1-IN-6 is an orally active compound that effectively inhibits mutant isocitrate dehydrogenase (IDH) enzymes. It demonstrates potency and selectivity, with IC50 values of 6.27, 3.71, 36.9, and 11.5 nM for IDH1 R132H, IDH1 R132C, IDH2 R140Q, and IDH2 R172K mutants, respectively. Notably, Mutant IDH1-IN-6 exhibits lower activity in inhibiting wild-type IDH enzymes. Target: Others. Smiles: CCN1C(=O)OCc2cnc(N[C@@H](C)c3ccc(cc3)[C@H](CC3CC3)N3CCN(CC3)C(=O)C=C)nc12. References: Renato Alejandro BAUER, et al. 7-phenylethylamino-4h-pyrimido[4,5-d][1,3]oxazin-2-one compounds as mutant idh1 and idh2 inhibitors. WO2018111707A1.
Keywords: Mutant IDH1-IN-6
Supplier: TargetMol
Supplier-Nr: T39716

Properties

Application: Targets isocitrate dehydrogenase [EC:1.1.1.42] (IDH1, IDH2, icd)
MW: 504.635 D
Formula: C28H36N6O3

Database Information

CAS : 2230263-60-0| Matching products
KEGG ID : K00031 | Matching products

Handling & Safety

Storage: +4°C
Shipping: +4°C (International: +4°C)
Caution
Our products are for laboratory research use only: Not for administration to humans!
Information about the product reference will follow. more
You will get a certificate here
or to request a certificate of analysis.
Read, write and discuss reviews... more
Customer review for "Mutant IDH1-IN-6"
Write a review
or to review a product.
Viewed